SEC 13F Intelligence

Aju Ib Investment Co., Ltd. / AVIR

Aju Ib Investment Co., Ltd.’s Atea Pharmaceuticals Inc Position

Does Aju Ib Investment Co., Ltd. own Atea Pharmaceuticals Inc (AVIR)? Not currently — the last reported position was 1.64M shares worth $57M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$57M
Q3 2021
Shares
1.64M
% of Portfolio
+37.04%
Quarters Held
3
position exited

Position History AVIR

Reported value by quarter
Q1 ’21: $127MQ1 ’21Q2 ’21: $37MQ2 ’21Q3 ’21: $57MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20211.64M$57M+37.04%
Q2 20211.75M$37M+21.62%
Q1 20212.05M$127M+47.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aju Ib Investment Co., Ltd.’s full portfolio or all institutional holders of AVIR.